PATENT CLAIM ANALYSIS

Application Number: 15753775
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["435", "006140"]

Abstract:
The object of the invention is to elucidate a new causative gene of cancer, polynucleotide, and thereby provide a method for detecting the polynucleotide or a polypeptide that is encoded by the polynucleotide, as well as a primer set or a detection kit for such detection. The detection method detects a fusion gene of a part of an OCLN gene and a part of an ARHGAP26 gene, or a fusion protein encoded by such gene. The primer set includes a sense primer designed from a section encoding OCLN and an antisense primer designed from a section encoding ARHGAP26.

Claim (Index 14):
The primer set according to  claim 13 , wherein the sense primer consists of an oligonucleotide of at least 16 random consecutive bases between base no. 1 to 891 of SEQ ID NO: 1, and the antisense primer consists of an oligonucleotide complementary to an oligonucleotide of at least 16 random consecutive bases between base no. 892 to 2064 of SEQ ID NO: 1.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 88.0
- Lexical Diversity: 2.1875
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15753994', '14383199', '13805513', '14643181', '15113599']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6837893502626334
- 35 USC 102 Novelty (BERT): 0.53866863831851
- Combined Prediction Score: 0.6692772790682211
- Mean Citation Score: 347.070356
- Max Citation Score: 390.56677
- Similarity Product: 322.7170908336758

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test